Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
Trial record 1 of 1 for:    SGI-110 hepatocellular carcinoma
Previous Study | Return to List | Next Study

SGI-110 in the Treatment of Advanced Hepatocellular Carcinoma (HCC)

This study has been completed.
Information provided by (Responsible Party):
Astex Pharmaceuticals Identifier:
First received: December 17, 2012
Last updated: December 28, 2015
Last verified: December 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2015
  Primary Completion Date: September 2015 (Final data collection date for primary outcome measure)